PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY Trademark

Trademark Overview

On Friday, June 23, 2017, a trademark application was filed for PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY with the United States Patent and Trademark Office. The USPTO has given the PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY trademark a serial number of 87982664. The federal status of this trademark filing is REGISTERED as of Tuesday, March 10, 2020. This trademark is owned by Plexxikon Inc.. The PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product development research, product development, and product development consultation regarding pharmaceutical, biological and biotechnological products; Pharmaceutical research and development services; medical research and development services in the field of treatments for cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders
plexxikon scaffold-based drug discovery

General Information

Serial Number87982664
Word MarkPLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Filing DateFriday, June 23, 2017
Status700 - REGISTERED
Status DateTuesday, March 10, 2020
Registration Number6008629
Registration DateTuesday, March 10, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 14, 2017

Trademark Statements

Description of MarkThe mark consists of four circles connected by short lines in a manner of a molecular model, all inside of a larger circle and stacked on top of the word "PLEXXIKON", with the words "SCAFFOLD-BASED DRUG DISCOVERY" underneath all.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"SCAFFOLD-BASED DRUG DISCOVERY"
Goods and ServicesProduct development research, product development, and product development consultation regarding pharmaceutical, biological and biotechnological products; Pharmaceutical research and development services; medical research and development services in the field of treatments for cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 30, 2017
Primary Code042
First Use Anywhere DateThursday, October 10, 2019
First Use In Commerce DateThursday, October 10, 2019

Trademark Owner History

Party NamePlexxikon Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710
Party NamePlexxikon Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710
Party NamePlexxikon Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710

Trademark Events

Event DateEvent Description
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 10, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, February 4, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 4, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 3, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 3, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, January 6, 2020USE AMENDMENT FILED
Monday, February 3, 2020DIVISIONAL PROCESSING COMPLETE
Monday, January 6, 2020DIVISIONAL REQUEST RECEIVED
Monday, February 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 6, 2020TEAS REQUEST TO DIVIDE RECEIVED
Monday, January 6, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, January 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 2, 2020SOU EXTENSION 4 GRANTED
Thursday, January 2, 2020SOU EXTENSION 4 FILED
Thursday, January 2, 2020TEAS EXTENSION RECEIVED
Wednesday, July 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 1, 2019SOU EXTENSION 3 GRANTED
Monday, July 1, 2019SOU EXTENSION 3 FILED
Monday, July 1, 2019TEAS EXTENSION RECEIVED
Tuesday, January 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 4, 2019SOU EXTENSION 2 GRANTED
Friday, January 4, 2019SOU EXTENSION 2 FILED
Friday, January 4, 2019TEAS EXTENSION RECEIVED
Saturday, July 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 5, 2018SOU EXTENSION 1 GRANTED
Thursday, July 5, 2018SOU EXTENSION 1 FILED
Thursday, July 5, 2018TEAS EXTENSION RECEIVED
Tuesday, January 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 9, 2017ASSIGNED TO LIE
Friday, September 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 22, 2017EXAMINER'S AMENDMENT ENTERED
Friday, September 22, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 22, 2017EXAMINERS AMENDMENT E-MAILED
Friday, September 22, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, September 21, 2017ASSIGNED TO EXAMINER
Saturday, July 1, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 27, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

discovery drug based scaffold plexxikon development product research services pharmaceutical system central nervous metabolic disorders